10 months ago
Chinese ADC Drug Targeting B7-H3 Approved for Clinical Trials! ADC #ADC #Immunotherapy#B7H3 #LungCancer #HeadAndNeckCancer #ADCDrug On September 20, the China National Medical Products Administrati...
10 months ago
Yescarta Indications Yescarta, known by its generic name axicabtagene ciloleucel, is a groundbreaking CAR-T cell therapy. It has significantly impacted the treatment landscape for certain types of ...
10 months ago
The Lancet | Chinese Medical Team: A New Breakthrough in the Treatment of Limited-stage Small Cell Lung Cancer! High-dose Accelerated Hyperfractionated Radiotherapy Helps Improve Treatment Effic...
10 months ago
Yescarta Follicular Lymphoma FDA On March 5, 2021, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Yescarta (axicabtagene ciloleucel),...
10 months ago
Yescarta Follicular Lymphoma: A Breakthrough in Treatment On March 5, 2021, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Yescarta (axicabtagene ciloleucel) for the tr...
10 months ago
Yescarta FDA Approval Date Yescarta (Axicabtagene Ciloleucel), a revolutionary CAR-T cell therapy, has garnered significant attention since its FDA approval in 2017. This article aims to provide a ...
10 months ago
**Published in Cell Journal | Breakthrough in dMMR Metastatic Colorectal Cancer Treatment: Chinese Research Garners International Recognition** Colorectal Cancer #ColorectalCancer #PD1Antibody #dMM...
10 months ago
**Breakthrough in China’s CAR-T Therapy: 13-Year-Old Girl Overcomes Lupus, Opening New Hope for a Cure** Lupus #LupusTreatment #HopeForLupus #lupus #AutoimmuneDisease #ChinaHealthcare #System...
10 months ago
**Hematologic Tumors** – Detection: Unveiling the Mysteries of the Disease #Hematologic #BloodCancer #CancerDetection #Leukemia #Lymphoma #MultipleMyeloma Hematologic tumors are a grou...
10 months ago
**”Curing” the Untouchable Cancer – Systemic Lupus Erythematosus: Chinese Experts Take a Major Leap Forward** Lupus #LupusTreatment #HopeForLupus #lupus #AutoimmuneDisease #China...
10 months ago
Yescarta EU Approval: A Revolutionary CAR-T Cell Therapy for Lymphoma Patients On October 17, 2022, the European Commission (EC) granted approval for the use of Yescarta® (axicabtagene ciloleucel) ...
10 months ago
Yescarta Drug: A Breakthrough in Lymphoma Treatment Yescarta (Axicabtagene ciloleucel, Axi-cel) has revolutionized the treatment landscape for lymphoma since its initial approval by the US FDA on O...
By using our site, you agree to our Terms and Conditions and Privacy Policy.Advanced Medicine In China does not provide medical advice, diagnosis, or treatment. The information provided on this site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her existing physician.
© Copyright 2023 Advanced Medicine In China. All rights reserved.
